Results 221 to 230 of about 314,989 (266)

Infusion Therapies in Rheumatic Practice

JCR: Journal of Clinical Rheumatology, 2000
Infusion therapies have been used in rheumatology practice for many years. However, the recent approval of infliximab for rheumatoid arthritis and the development of a host of i.v. treatments for inflammatory rheumatic and metabolic bone disorders will likely have a significant impact on the use of infusion therapies by rheumatologists.
O, Gluck, M, Maricic
openaire   +2 more sources

Copper infusion therapy in trichopoliodystrophy

The Journal of Pediatrics, 1975
The effect of repeated intravenous infusions of cupric salts was studied in two patients (cousins) with trichopoliodystrophy identified at the ages of 3 days and 2 and-one-half mo, respectively. The intravenous doses of copper were gradually increased and normal or near-normal serum values were achieved after 150 mug/Cu2+/kg were administered daily for
W D, Grover, M C, Scrutton
openaire   +2 more sources

Continuous infusion therapy in haemophilia

Haemophilia, 1998
Summary. The application of coagulation factor therapy by continuous infusion (CI) was first suggested by Brinkhous in the early 1950s [1]. The recent introduction of this mode of therapy to everyday practice was made possible after the demonstration of a good stability of most factor concentrates which were also found safe regarding potential ...
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, D. VARON, U. MARTINOWITZ   +6 more
openaire   +2 more sources

Infusion Therapy and Implantables for the Urologist

Urologic Clinics of North America, 2013
The specialty of urology has historically adapted to the changing health care environment. Urologists have been quick to adopt new technology, new therapeutics, and devices to render state-of-the-art patient care with improved clinical outcomes. The busy urology practice is now in the position to deliver many novel and unique therapies across multiple ...
Jennifer, Rothschild, Ian M, Thompson, Raoul S, Concepcion, Neal D, Shore   +3 more
openaire   +2 more sources

Infusion of Antineoplastic Therapies in the Home

Oncology Nursing Forum, 2020
Infusion of antineoplastic medications in nontraditional settings, including the home, is not a new concept. However, the emergence of the novel coronavirus, COVID-19, has accelerated conversations around ensuring that patients with cancer can continue timely cancer treatment regimens while minimizing their risk of COVID-19 exposure and infection ...
openaire   +2 more sources

Stopcocks for Infusion Therapy

Journal of Infusion Nursing, 2018
Stopcocks have been used for decades to deliver infusion therapy in patients of all ages and in all health care settings. During the past 20 years, a growing number of studies have validated concern about the risk of the open lumen allowing intraluminal contamination. Additional studies highlight fluid flow dynamics associated with stopcocks.
openaire   +2 more sources

Prophylactic Infusion Therapy in Hemophilia

Hospital Practice, 1979
When part of a program of comprehensive care and patient-family education, home infusion of the missing coagulation factor by patient or parent can provide a high degree of hemorrhage control, or even complete prophylaxis, enabling the great majority of patients with hemophilia to lead nearly normal lives.
openaire   +2 more sources

[Are maltose infusions suitable for infusion therapy].

Infusionstherapie und klinische Ernahrung, 1976
The suitability of maltose for parenteral nutrition was investigated in metabolically healthy volunteers. A solution containing 20% of maltose was infused intravenously for four hours using three different doses (0.125 g/kg; 0.25 g/kg; 0.5 g/kg BW/h). Following cessation of the infusions the laboratory controls were carried on for four more hours.
H, Fŏrster, I, Hoos, S, Boecker, B, Michel   +3 more
openaire   +1 more source

Insulin infusion therapy

Postgraduate Medicine, 1985
A mass of evidence favors the concept of euglycemic management of insulin-dependent diabetes, despite significant potential complications. Patients with advanced nephropathy and/or autonomic neuropathy are very poor risks, and infusion therapy does not reverse well-established complications. To well-motivated, educated patients, infusion therapy offers
openaire   +2 more sources

Clonidine Infusion Therapy

2019
Clonidine, an ⍺-adrenergic imidazoline derivative, was developed in the 1960’s to treat nasal congestion (Stahle, Best Pract Res Clin Anaesthesiol. 14:237–46, 2000). Researchers quickly discovered its decongestant properties was accompanied with significant hypotension and bradycardia (Stahle, Best Pract Res Clin Anaesthesiol.
Nam K. Ly, Jon Livelsberger, Rany T. Abdallah   +2 more
openaire   +1 more source